/orphanin FQ (N/OFQ), the nociceptin opioid peptide (NOP) receptor ligand, increases feeding when injected centrally. Initial data suggest that N/OFQ blocks the development of a conditioned taste aversion (CTA). The current project further characterized the involvement of N/OFQ in the regulation of hunger vs. aversive responses in rats by employing behavioral, immunohistochemical, and real-time PCR methodology. We determined that the same low dose of the NOP antagonist [Nphe 1 ]N/OFQ(1-13)NH2 delivered via the lateral ventricle diminishes both N/OFQand deprivation-induced feeding. This anorexigenic effect did not stem from aversive consequences, as the antagonist did not cause the development of a CTA. When [Nphe 1 ]N/OFQ(1-13)NH2 was administered with LiCl, it moderately delayed extinction of the LiClinduced CTA. Injection of LiCl ϩ antagonist compared with LiCl alone generated an increase in c-Fos immunoreactivity in the central nucleus of the amygdala. The antagonist alone elevated Fos immunoreactivity in the paraventricular nucleus of the hypothalamus, nucleus of the solitary tract, and central nucleus of the amygdala. Hypothalamic NOP mRNA levels were decreased during energy intake restriction induced by aversion, as well as in non-CTA rats food-restricted to match CTA-reduced consumption. Brain stem NOP was upregulated only in aversion. Prepro-N/OFQ mRNA showed a trend toward upregulation in restricted rats (P ϭ 0.068). We conclude that the N/OFQ system promotes feeding by affecting the need to replenish lacking calories and by reducing aversive responsiveness. It may belong to mechanisms that shift a balance between the drive to ingest energy and avoidance of potentially tainted food. food intake; conditioning; hypothalamus; brain stem; amygdala; lithium chloride; NOP receptor; ORL1 NOCICEPTIN/ORPHANIN FQ (N/OFQ) is a 17-amino acid endogenous agonist of the opioid-like G protein-coupled receptor ORL1, currently referred to as the nociceptin opioid peptide (NOP) receptor (20,32). N/OFQ and the NOP exhibit a high degree of structural homology to dynorphin and the -opioid receptor, respectively (3, 9). Regardless of this similarity, N/OFQ does not activate opioid receptors, nor does the NOP bind classical opioid receptor ligands (36). The N/OFQ system has been implicated in several physiological and behavioral functions, including regulation of water-electrolyte balance (16), pain perception (5), locomotion (10), sexual behavior (37), and memory and learning (35).The high level of homology between N/OFQ and opioids prompted the following question: Does N/OFQ, similar to opioids (23), elicit hyperphagia? Pomonis et al. (29) reported that lateral ventricular (LV) administration of this peptide moderately increases chow intake; in subsequent studies, mild overeating was also observed following site-specific, but not peripheral, injections of N/OFQ (28, 38). Unlike classical opioids, N/OFQ primarily affects eating for energy, not for palatability (22,28).Aside from N/OFQ's involvement in the control of hunge...